These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24924305)

  • 41. Red-Emissive Guanylated Polyene-Functionalized Carbon Dots Arm Oral Epithelia against Invasive Fungal Infections.
    Li X; Huang R; Tang FK; Li WC; Wong SSW; Leung KC; Jin L
    ACS Appl Mater Interfaces; 2019 Dec; 11(50):46591-46603. PubMed ID: 31742377
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida.
    Mandras N; Nostro A; Roana J; Scalas D; Banche G; Ghisetti V; Del Re S; Fucale G; Cuffini AM; Tullio V
    BMC Complement Altern Med; 2016 Aug; 16(1):330. PubMed ID: 27576581
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anticandidal activity of synthetic peptides: Mechanism of action revealed by scanning electron and fluorescence microscopies and synergism effect with nystatin.
    Lima PG; Souza PFN; Freitas CDT; Oliveira JTA; Dias LP; Neto JXS; Vasconcelos IM; Lopes JLS; Sousa DOB
    J Pept Sci; 2020 Jun; 26(6):e3249. PubMed ID: 32189445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis].
    Kutsyk RV; Pavliuk TD
    Mikrobiol Z; 2003; 65(5):26-9. PubMed ID: 14723159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents.
    Ellepola AN; Samaranayake LP
    Arch Oral Biol; 1998 Dec; 43(12):999-1007. PubMed ID: 9877331
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular Umbrellas Modulate the Selective Toxicity of Polyene Macrolide Antifungals.
    Skwarecki AS; Skarbek K; Martynow D; Serocki M; Bylińska I; Milewska MJ; Milewski S
    Bioconjug Chem; 2018 Apr; 29(4):1454-1465. PubMed ID: 29485855
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The in vitro adhesion of Candida albicans to buccal epithelial cells (BEC) from diabetic and non-diabetic individuals after in vivo and in vitro application of nystatin.
    Darwazeh AM; MacFarlane TW; Lamey PJ
    J Oral Pathol Med; 1997 May; 26(5):233-6. PubMed ID: 9178175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adhesion of oral C. albicans to human buccal epithelial cells following limited exposure to antifungal agents.
    Ellepola AN; Samaranayake LP
    J Oral Pathol Med; 1998 Aug; 27(7):325-32. PubMed ID: 9725570
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro pharmacodynamic characteristics of nystatin including time-kill and postantifungal effect.
    Gunderson SM; Hoffman H; Ernst EJ; Pfaller MA; Klepser ME
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2887-90. PubMed ID: 10991881
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new acridone with antifungal properties against Candida spp. and dermatophytes, and antibiofilm activity against C. albicans.
    de Oliveira DBC; Silva LB; da Silva BV; Borges TC; Marques BC; Dos Santos MB; de Oliveira LF; Bolzani VS; Rodrigues ARA; Regasini LO; Andrade AA
    J Appl Microbiol; 2019 Nov; 127(5):1362-1372. PubMed ID: 31297951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Experimental evidences for a role of subinhibitory concentrations of rilopirox, nystatin and fluconazole on adherence of Candida spp. to vaginal epithelial cells.
    Braga PC; Maci S; Dal Sasso M; Bohn M
    Chemotherapy; 1996; 42(4):259-65. PubMed ID: 8804793
    [TBL] [Abstract][Full Text] [Related]  

  • 53. β-lactam substituted polycyclic fused pyrrolidine/pyrrolizidine derivatives eradicate C. albicans in an ex vivo human dentinal tubule model by inhibiting sterol 14-α demethylase and cAMP pathway.
    Gowri M; Sofi Beaula W; Biswal J; Dhamodharan P; Saiharish R; Rohan prasad S; Pitani R; Kandaswamy D; Raghunathan R; Jeyakanthan J; Rayala SK; Venkatraman G
    Biochim Biophys Acta; 2016 Apr; 1860(4):636-47. PubMed ID: 26723175
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis.
    Fan SR; Liu XP
    Mycoses; 2011 Nov; 54(6):501-5. PubMed ID: 20406393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
    Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
    J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of antimicrobial agents incorporated into resilient denture relines on the Candida albicans biofilm.
    Bueno MG; Urban VM; Barbério GS; da Silva WJ; Porto VC; Pinto L; Neppelenbroek KH
    Oral Dis; 2015 Jan; 21(1):57-65. PubMed ID: 24219354
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of new nystatin and polyfungin derivatives as compared to original antibiotics on Candida strains isolated from patients with recurrent mycoses.
    Kwaśniewska J
    Mater Med Pol; 1988; 20(4):233-7. PubMed ID: 3249541
    [No Abstract]   [Full Text] [Related]  

  • 58. Inhibitory Effect of Standardized Extract and Fractions of
    Jahantiq AS; Ayatollahi Mousavi SA; Mohamadi N; Sharififar F
    Curr Drug Discov Technol; 2022; 19(5):e120522204695. PubMed ID: 35549875
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Innovative formulation of nystatin particulate systems in toothpaste for candidiasis treatment.
    Pinto Reis C; Vasques Roque L; Baptista M; Rijo P
    Pharm Dev Technol; 2016; 21(3):282-7. PubMed ID: 25567611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antifungal potential of Sideroxylon obtusifolium and Syzygium cumini and their mode of action against Candida albicans.
    Pereira JV; Freires IA; Castilho AR; da Cunha MG; Alves Hda S; Rosalen PL
    Pharm Biol; 2016 Oct; 54(10):2312-9. PubMed ID: 26987037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.